
Ontario built a process to vet the AI scribe tools now sold to doctors, nurse practitioners, and therapists — and its Auditor General found that during testing, every approved system produced at least one error, from fabricated clinical findings to the wrong medication, with the work of catching those errors left to the clinician. For any practice weighing one of these tools, the due diligence the process skipped is now yours to do. This article breaks down what the audit found and the questions worth asking a vendor before you sign.







